Congress Topics

Congress Topics

Acute asthma

Causes and risk factors
Management and prevention
Asthma in the ICU 

Allergic Rhinitis Impact on Asthma

Pathophysiology of Allergic Rhinitis and Asthma
Impact of Allergic Rhinitis Therapies in Asthma
Allergen Immunotherapy in Asthma 


Allergy testing
Aero-allergens and airways
The ARIA initiative

Asthma and COPD

Influence of Tobacco on asthma
Is Asthma COPD overlap a distinct entity
Management of ACO

Asthma and specific conditions and populations

Asthma and pregnancy
Asthma in the elderly
Managing Allergy & Asthma in Resource Poor Settings
Asthma in the obese
Occupational asthma

Asthma co-morbidities

Asthma and rhinitis
Asthma and upper airways dysfunction
Obesity and asthma
Chronic Rhinosinusitis and T2 inflammation
Asthma and nasal polyps

Asthma diagnosis

Under and overtreatment of asthma
Standards for the diagnosis of asthma
Pulmonary function tests

Asthma epidemiology

Incidence and prevalence of asthma in the world
Morbidity and mortality from asthma
Natural history of severe asthma: can it be altered

Asthma pathophysiology

Airway inflammation subtypes
Airway remodeling

Asthma phenotypes

Asthma phenotyping
Severe asthma
Occupational asthma
Exercise-induced asthma and asthma in the athlete
Eosinophilic asthma
Non-eosinophilic asthma
T2 vs Non-T2 asthma
Obesity and asthma

Asthma treatment

Care gaps
Management of mild asthma
New asthma guidelines
New inhalers
Future treatment of asthma
Non-pharmacologic asthma therapies
Non-biologic treatments for asthma
Impact of new Asthma Biologicals on Asthma Outcomes
Is there still a role of OCS in long-term treatment of severe asthma ?
Is there still a role of SABAs in long-term treatment of severe asthma ?

Clinical aspects of asthma: the patient perspective

Perception of asthma symptoms
Asthma education

Drugs for asthma and COPD

Inhaled corticosteroids
Leukotriene antagonists
Combination therapies (double and triple therapy)
Monoclonal antibodies

Environmental factors and asthma

Workplace inhalants
Air pollution
Climate change

GINA update

New GINA report in adolescent and adults
New GINA report in children
GINA recommendations on severe asthma

Non-invasive airway inflammation assessment

The role of inflammometry in asthma
Blood and Induced sputum analysis
Exhaled NO measures

Precision medicine

Personalized medicine: how to make it happen
Biomarkers of asthma
Targeting asthma therapy
IL5 versus IgE as a Therapeutics target in Asthma
Other cytokines antagonists

COVID-19 and other respiratory infections and asthma

The COVID Pandemic and asthma
Severe COVID pneumonia management
Other Bacterial and Viral infections

Risk factors of asthma

Vitamin deficiency and nutritional factors
Smoking (direct and secondary)
Exposure to bacteria (microbiome)
Genetic factors

Severe asthma

Assessment of severe asthma
Management of difficult-to-control asthma
Severe pediatric asthma
New monoclonal antibodies
Can we predict response to therapies
New therapies to come

Various topics on asthma

History of asthma and its treatment
Conditions mimicking asthma
RCTs or Real-life trials ?
WHO-GARD, ARIA and ISAR initiatives
Surveys of biologics use in asthma